Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic <i>Escherichia coli</i> among Children in Zambia Participating in a Phase I Clinical Trial

Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic <i>Escherichia coli</i> among Children in Zambia Participating in a Phase I Clinical Trial

Diarrhoeagenic <i>E. coli</i> (DEC) significantly contributes to the burden of diarrhoea among children. Currently, there is no approved vaccine against DEC, but several vaccines against the enterotoxigenic <i>E. coli</i> (ETEC) pathotype are in advanced clinical trial stages...

Full description

Bibliographic Details
Main Authors: Kapambwe Mwape, Cynthia Mubanga, Obvious Nchimunya Chilyabanyama, Kennedy Chibesa, Caroline Cleopatra Chisenga, Suwilanji Silwamba, Arlo Randall, Xiaowu Liang, Tobias George Barnard, Michelo Simuyandi, Roma Chilengi
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Microorganisms
Subjects:
microarray
vaccines
diarrhoeagenic <i>E. coli</i>
diarrhoea
cross-reactivity
ETVAX vaccine
Online Access:https://www.mdpi.com/2076-2607/12/3/420

Internet

https://www.mdpi.com/2076-2607/12/3/420

Similar Items